The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development

International Journal for Parasitology

Volumn 42, Issue 9, 2012, Pages 859-870

  Inoue, Megumi ^a   Tang, Jianxia ^b   Miyakoda, Mana ^a   Kaneko, Osamu ^a   Yui, Katsuyuki ^a   Culleton, Richard ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b BEIJING HOSPITAL   (China)

Author keywords

Blood stage; Malaria vaccine; Plasmodium vinckei; Plasmodium yoelii; Pre erythrocytic stage; Sporozoite vaccine

Indexed keywords

COMPLEMENTARY DNA; MEFLOQUINE; PARASITE ANTIGEN;

BLOOD; DRUG DEVELOPMENT; IMMUNE SYSTEM; MALARIA; PARASITE; PARASITOLOGY; VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; FEMALE; GENETIC DISTANCE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VINCKEI; PLASMODIUM VINCKEI INFECTION; PLASMODIUM YOELII; PLASMODIUM YOELII INFECTION; T CELL DEPLETION; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTIBODIES, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; ERYTHROCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PARASITEMIA; PLASMODIUM; REAL-TIME POLYMERASE CHAIN REACTION; RNA, PROTOZOAN; SPECIES SPECIFICITY; VACCINES, ATTENUATED;

PLASMODIUM VINCKEI; PLASMODIUM VINCKEI LENTUM; PLASMODIUM YOELII; PLASMODIUM YOELII YOELII; RODENTIA;

EID: 84865437178     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.07.001     Document Type: Article

References (63)

1. Ahvazi B.C., Jacobs P., Stevenson M.M. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. J. Leukoc. Biol. 1995, 58:23-31.
2. Belnoue E., Costa F., Frankenberg T., Vigário A., Voza T., Leroy N., Rodrigues M., Landau I., Snounou G., Rénia L. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 2004, 172:2487-2582.
3. Belnoue E., Voza T., Costa F.T., Gruner A.C., Mauduit M., Rosa D.S., Depinay N., Kayibanda M., Vigario A.M., Mazier D., Snounou G., Sinnis P., Renia L. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J. Immunol. 2008, 181:8552-8558.
4. Butler N., Schmidt N., Vaughan A., Aly A., Kappe S., Harty J. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 2011, 9:451-513.
5. + T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 2007, 13:1035-1041.
6. Doolan D.L., Sedegah M., Hedstrom R.C., Hobart P., Charoenvit Y., Hoffman S.L. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 1996, 183:1739-1746.
7. + T cell response in the liver. J. Immune Based Ther. Vaccines 2011, 9:6.
8. Engwerda C.R., Good M.F. Interactions between malaria parasites and the host immune system. Curr. Opin. Immunol. 2005, 17:381-387.
9. + T cell immunity. Science 2011, 334:475-555.
10. Frevert U. Sneaking in through the back entrance: the biology of malaria liver stages. Trends Parasitol. 2004, 20:417-441.
11. Gerald N., Majam V., Mahajan B., Kozakai Y., Kumar S. Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites. PLoS ONE 2011, 6.
12. Golenser J., Spira D.T., Verhave J.P., Meuwissen J.H. Specific lymphocyte transformation in murine malaria. Z. Parasitenkd. 1976, 50:95-98.
13. Good M. A whole parasite vaccine to control the blood stages of Plasmodium - the case for lateral thinking. Trends Parasitol. 2011, 27:335-340.
14. Good M., Doolan D. Malaria's journey through the lymph node. Nat. Med. 2007, 13:1023-1027.
15. Greenwood B.M., Bradley-Moore A.M., Bryceson A.D., Palit A. Immunosuppression in children with malaria. Lancet 1972, 1:169-172.
16. Gruner A.C., Mauduit M., Tewari R., Romero J.F., Depinay N., Kayibanda M., Lallemand E., Chavatte J.M., Crisanti A., Sinnis P., Mazier D., Corradin G., Snounou G., Renia L. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS ONE 2007, 2:e1371.
17. Gueirard P., Tavares J., Thiberge S., Bernex F., Ishino T., Milon G., Franke-Fayard B., Janse C., Ménard R., Amino R. Development of the malaria parasite in the skin of the mammalian host. Proc. Natl. Acad. Sci. USA 2010, 107:18640-18645.
18. Guerra C., Snow R., Hay S. Mapping the global extent of malaria in 2005. Trends Parasitol. 2006, 22:353-361.
19. Gunewardena D., Carter R., Mendis K. Patterns of acquired anti-malarial immunity in Sri Lanka. Memórias do Instituto Oswaldo Cruz 1994, 89(Suppl. 2):63-68.
20. + T cells. J. Immunol. 1997, 159:3400-3411.
21. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., Sacci J., de la Vega P., Dowler M., Paul C., Gordon D.M., Stoute J.A., Church L.W., Sedegah M., Heppner D.G., Ballou W.R., Richie T.L. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 2002, 185:1155-1164.
22. Inoue M., Culleton R.L. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies. Parasite Immunol. 2011, 33:137-142.
23. + T cells. J. Infect. Dis. 2007, 196:599-607.
24. Kawabata Y., Udono H., Honma K., Ueda M., Mukae H., Kadota J., Kohno S., Yui K. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii. Infect. Immun. 2002, 70:6075-6082.
25. Khusmith S., Charoenvit Y., Kumar S., Sedegah M., Beaudoin R.L., Hoffman S.L. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 1991, 252:715-718.
26. Kumar K.A., Baxter P., Tarun A.S., Kappe S.H., Nussenzweig V. Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites. PLoS ONE 2009, 4:e4480.
27. Maitland K., Williams T., Newbold C. Plasmodium vivax and P. falciparum: biological interactions and the possibility of cross-species immunity. Parasitol. Today 1997, 13:227-258.
28. Mauduit M., Gruner A.C., Tewari R., Depinay N., Kayibanda M., Chavatte J.M., Franetich J.F., Crisanti A., Mazier D., Snounou G., Renia L. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS ONE 2009, 4:e7717.
29. Mauduit M., Tewari R., Depinay N., Kayibanda M., Lallemand E., Chavatte J.M., Snounou G., Renia L., Gruner A.C. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect. Immun. 2010, 78:2182-2188.
30. Mayxay M., Pukrittayakamee S., Newton P.N., White N.J. Mixed-species malaria infections in humans. Trends Parasitol. 2004, 20:233-240.
31. McCarthy J.S., Good M.F. Whole parasite blood stage malaria vaccines: a convergence of evidence. Hum. Vaccin 2010, 6:114-123.
32. McColm A.A., Dalton L. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection. Ann. Trop. Med. Parasitol. 1983, 77:355-377.
33. Medica D.L., Sinnis P. Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect. Immun. 2005, 73:4363-4369.
34. Mendis K., David P., Carter R. Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines. Int. J. Parasitol. 1990, 20:497-502.
35. Mueller I., Zimmerman P., Reeder J. Plasmodium malariae and Plasmodium ovale-the " bashful" malaria parasites. Trends Parasitol. 2007, 23:278-361.
36. Murray C., Rosenfeld L., Lim S., Andrews K., Foreman K., Haring D., Fullman N., Naghavi M., Lozano R., Lopez A. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-444.
37. Nussenzweig R., Vanderberg J., Most H., Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967, 216:160-162.
38. Nussenzweig R.S., Vanderberg J.P., Most H., Orton C. Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites. Nature 1969, 222:488-489.
39. Nussenzweig R.S., Chen D. The antibody response to sporozoites of simian and human malaria parasites: its stage and species specificity and strain cross-reactivity. Bull. World Health Organ. 1974, 50:293-297.
40. Ocana-Morgner C., Mota M.M., Rodriguez A. Malaria blood stage suppression of liver stage immunity by dendritic cells. J. Exp. Med. 2003, 197:143-151.
41. Orjih A.U. Acute malaria prolongs susceptibility of mice to Plasmodium berghei sporozoite infection. Clin. Exp. Immunol. 1985, 61:67-71.
42. Perkins S.L., Sarkar I.N., Carter R. The phylogeny of rodent malaria parasites: simultaneous analysis across three genomes. Infect. Genet. Evol. 2007, 7:74-83.
43. Pinzon-Charry A., Good M.F. Malaria vaccines: the case for a whole-organism approach. Expert Opin. Biol. Ther. 2008, 8:441-448.
44. Pombo D.J., Lawrence G., Hirunpetcharat C., Rzepczyk C., Bryden M., Cloonan N., Anderson K., Mahakunkijcharoen Y., Martin L.B., Wilson D., Elliott S., Eisen D.P., Weinberg J.B., Saul A., Good M.F. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 2002, 360:610-617.
45. Purcell L.A., Wong K.A., Yanow S.K., Lee M., Spithill T.W., Rodriguez A. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine 2008, 26:4880-4884.
46. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 1991, 3:579-664.
47. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., van de Vegte-Bolmer M., van Schaijk B., Teelen K., Arens T., Spaarman L., de Mast Q., Roeffen W., Snounou G., Renia L., van der Ven A., Hermsen C.C., Sauerwein R. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 2009, 361:468-477.
48. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341:323-326.
49. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330:664-666.
50. Schwenk R., Richie T. Protective immunity to pre-erythrocytic stage malaria. Trends Parasitol. 2011, 27:306-320.
51. Sedegah M., Weiss W.W., Hoffman S.L. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites. Parasite Immunol. 2007, 29:559-565.
52. Soe S., Theisen M., Roussilhon C., Aye K.S., Druilhe P. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect. Immun. 2004, 72:247-252.
53. Stewart M.J., Nawrot R.J., Schulman S., Vanderberg J.P. Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies. Infect. Immun. 1986, 51:859-864.
54. Tarun A., Peng X., Dumpit R., Ogata Y., Silva-Rivera H., Camargo N., Daly T., Bergman L., Kappe S. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. USA 2008, 105:305-315.
55. Timms R., Colegrave N., Chan B.H., Read A.F. The effect of parasite dose on disease severity in the rodent malaria Plasmodium chabaudi. Parasitology 2001, 123:1-11.
56. Ting L.-M., Gissot M., Coppi A., Sinnis P., Kim K. Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat. Med. 2008, 14:954-962.
57. Voza T., Miller J.L., Kappe S.H., Sinnis P. Extrahepatic exoerythrocytic forms of rodent malaria parasites at the site of inoculation: clearance after immunization, susceptibility to primaquine and contribution to blood stage infection. Infect. Immun. 2012, 80:2158-2164.
58. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 1988, 85:573-576.
59. Weiss W.R. Host-parasite interactions and immunity to irradiated sporozoites. Immunol. Lett. 1990, 25:39-42.
60. Weiss W.R., Houghten R.A., Good M.F., Berzofsky J.A., Miller L.H., Hoffman S.L. A CTL epitope on the circumsporozoite protein of P. yoelii. Bull. World Health Organ. 1990, 68(Suppl. 2):99-103.
61. Williamson W.A., Greenwood B.M. Impairment of the immune response to vaccination after acute malaria. Lancet 1978, 1:1328-1329.
62. Wipasa J., Elliott S., Xu H., Good M.F. Immunity to asexual blood stage malaria and vaccine approaches. Immunol. Cell Biol. 2002, 80:401-414.
63. Zimmerman P.A., Mehlotra R.K., Kasehagen L.J., Kazura J.W. Why do we need to know more about mixed Plasmodium species infections in humans?. Trends Parasitol. 2004, 20:440-447.